Danhof M, Levy G
J Pharmacol Exp Ther. 1984 Apr;229(1):44-50.
The purpose of this investigation was to develop a method to determine the effect of various diseases on the concentration-pharmacologic activity relationship of phenobarbital (PB) in a manner that excludes or accounts for pharmacokinetic variables affecting drug disposition. Adult female rats (congruent to 180 g) received an i.v. infusion of PB at one of five different rates (0.412-4.12 mg/min) until the animals lost their righting reflex (after 8.0 +/- 0.4 to 62 +/- 10 min of infusion). The total dose, the serum concentration (both total and unbound drug) and the brain concentration of PB at onset of loss of righting reflex (LRR) increased with increasing infusion rate. The PB concentration in cerebrospinal fluid at onset of LRR (mean +/- S.D.: 108 +/- 19 micrograms/ml, n = 29) was not affected by the infusion rate. Concomitant infusion of PB and its p-hydroxy metabolite had no apparent effect on the concentrations of PB at onset of LRR even though the serum concentration of p-hydroxy PB was higher than upon infusion of PB only. The results of this investigation indicate that cerebrospinal fluid, unlike some regions of the brain, equilibrates very rapidly with the biophase of the receptors for PB-induced LRR. Determination of PB concentrations in the cerebrospinal fluid at the onset (rather than offset) of action facilitates assessment of the effect of diseases on the PB concentration-pharmacologic activity relationship by avoiding development of acute tolerance and excluding or minimizing effects due to disease-associated pharmacokinetic variables such as altered plasma protein binding and body distribution of the drug.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是开发一种方法,以一种排除或考虑影响药物处置的药代动力学变量的方式,来确定各种疾病对苯巴比妥(PB)浓度-药理活性关系的影响。成年雌性大鼠(约180 g)以五种不同速率之一(0.412 - 4.12 mg/min)静脉输注PB,直至动物失去翻正反射(输注8.0±0.4至62±10分钟后)。随着输注速率增加,翻正反射丧失(LRR)开始时PB的总剂量、血清浓度(总药物和游离药物)以及脑浓度均升高。LRR开始时脑脊液中PB的浓度(平均值±标准差:108±19μg/ml,n = 29)不受输注速率影响。即使对羟基PB的血清浓度高于仅输注PB时,同时输注PB及其对羟基代谢物对LRR开始时PB的浓度也没有明显影响。本研究结果表明,与脑的某些区域不同,脑脊液与PB诱导的LRR受体的生物相平衡非常迅速。在作用开始时(而非结束时)测定脑脊液中PB的浓度,通过避免急性耐受性的产生以及排除或最小化与疾病相关的药代动力学变量(如血浆蛋白结合改变和药物的体内分布)的影响,有助于评估疾病对PB浓度-药理活性关系的影响。(摘要截取自250字)